Clinical assessment of „Fitoprost\" - an extract of the plant Serenoa repens - in the treatment of early stages of benign prostatic hiperplasia
Article published in Urologia Polska 2001/54/3.

authors

Tadeusz Niezgoda, Zenona Jabłońska, Jarosław Kasprzak, Tomasz Szydełko, Janusz Dembowski, Jerzy Lorenz: Klinika Urologii AM we Wrocławiu
Kierownik kliniki: prof, dr hab. med. Jerzy Lorenz

keywords

prostate, benign prostatic hyperplasia, pharmacotherapy, Fitoprost

summary

Objectives. The aim of this study was the clinical assessment of Fitoprost - an extract of the Serenoa repens - the new phytome-dicine on polish market, used in treatment of BPH.

Material and method. 30 patients were treated with Fitoprost for 12 weeks. The dose was 320 mg/day (twice daily a capsule, each containing 160 mg of extract). Objective parameters like Qmax, Qave, Vres, subjective ones - measured with I-PSS and Quality of Life questionnaire and adverse events were evaluated.

Results. Statistically signifacant improvement was observed regarding Qmax, I-PSS and Quality of Life. No side effects were noticed.

Conclusions. Fitoprost is an effective medicine in patients suffering from early stages of BPH and its tolerance is good.

references

1. Borkowski A, Borówka A: Choroby gruczołu krokowego. Wydawnictwo Lekarskie PZWL, Warszawa, 1997.
2. Carraro J, Raynaud JP, Koch G, Chisholm G, Di Silveno F, Te-illac P, Da Silva F, Cauquil J, Chopin D, Hamdy F. Hanus M, Haun D, Kalinleris A, Marencak J, Pener A, Perrin P: Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of1098 patients. Prostate 1996; 29; 23-240.
3. Frohmiiller H, Thciss M, Bracher F: Prostataerkramtngen im hoheren Lebensalter. Wissenchaftliche Verlagsgesellschaft nihil Stuttgart, 1995.
4. Koch E, Biber A: Phannakologische Wirkungen von Sabahmd Urticaextntcten als Griindlage fur eine rationale medicumentóse Therapie der benignen Prostalahyperplasie. Uroloce [B] 1994; 34; 95-101.
5. Krysi P, Koźmińska E, Zdrojowy R, Jabłońska Z, Lorenz J,Borkowski A: Ocena skuteczności, bezpieczeństwa i tolerancji stosowania Pennixonu u chotych z objawowym, łagodnym rozrostem givczoht krokowego. Urologia Polska 2000; 53, 2; 244-252.
6. Schilcher H, Wiilker A: Phytotherapie in der Urologie. Hippo-krates-Verlag Stuttgart, 1992.
7. Schilcher H: Gibt es eine rationale Therapie zur symptomati-schen Behandlung der benignen Prostatahyperplasie mittels Phy-lopharmaka? Erlautet an Dcispiel der Prostatamittel des Serenoa repem (Sabal fructus). Wicn - Med Wochcnschaft 1999; 8-10; 236-240.

correspondence